Quarterly report pursuant to Section 13 or 15(d)

Revision of Prior Period Financial Statements - Revised Condensed Consolidated Statements of Cash Flows (Details)

v3.22.2.2
Revision of Prior Period Financial Statements - Revised Condensed Consolidated Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:                    
Net loss $ (25,686) $ (13,801)   $ (22,977) $ (13,506) $ (39,487) $ (36,483) $ (15,676) $ (10,888) $ (28,427)
Adjustments to reconcile net loss to net cash used in operating activities:                    
Depreciation and amortization 1,300 1,086   600 452 2,350 1,102 1,948 2,895 1,065
Write-off of inventory   324       425 0 400 2,132  
Adjustment to property and equipment for sales type leases   (625)       (625) 0   (91)  
Loss from impairment of property and equipment 316 96 $ 1,656 0   412 0 1,656 1,869  
Adjustment to property and equipment for sales type leases               659 617  
Stock-based compensation   3,927     309 8,988 1,376 6,032 9,596 1,579
Noncash interest expense   5     2,344 10 5,455 5,561 5,245 25
Noncash lease expense   197       392 0      
Provision recorded for allowance for doubtful accounts         (63) 80 (63) (63) (13) 47
Loss on extinguishment of debt 0   865 11,820   0 11,820 12,685 12,685 66
Change in fair value of derivative liability 0   (475) 795 1,425 0 2,220 1,745 1,745  
Change in fair value of common stock warrant liability 0   (42) 185 736 0 921 879 879  
Change in fair value of contingent earn-out liability 569 (3,078) (32,609) 0   (2,509) 0 (32,609) (47,360)  
Change in fair value of contingently issuable common stock liability 24 (1,472) (5,718) 0   (1,448) 0 (5,718) (6,406)  
Change in fair value of public warrant liability 143 (5,586) (3,152) 0   (5,443) 0 (3,152) (12,606)  
Changes in operating assets and liabilities                    
Accounts receivable   (2,112)     (874) (5,786) (1,335) (5,866) (5,063) (464)
Inventory   (1,310)     (480) (3,545) (453) (736) (3,436) (315)
Commission assets   (351)     (391) (339) (742) (1,102) (3,072) (1,785)
Contract assets   108     (119) (1,352) (239) (3,477) (4,877)  
Other assets   141     7 (756) 13 23 32 (173)
Prepaid expenses and other current assets   (5,571)     (3,727) (9,707) (7,287) (11,535) (9,148) (1,016)
Accounts payable   (855)     959 2,147 3,499 240 765 815
Deferred revenue   2,577     (806) 6,031 153 2,352 4,832 2,386
Deferred rent   0     (11) 0 152 397 457 (34)
Warranty reserve             (42) (42) (42) (14)
Accrued expenses and other current liabilities         1,306   1,641 2,834 2,472 2,643
Accrued expenses and other current liabilities   (2,433)       (1,876) 1,599      
Operating lease liability   (697)       (457)       0
Net cash used in operating activities   (29,430)     (12,439) (52,495) (18,292) (42,565) (56,781) (23,602)
Cash flows from investing activities:                    
Development of internal-use software   (728)       (1,301) 0   (1,028)  
Purchases of property and equipment   (6,689)     (2,121) (11,379) (7,954) (10,994) (16,557) (6,261)
Net cash used in investing activities   (7,417)     (2,121) (12,680) (7,954) (10,994) (17,585) (6,261)
Cash flows from financing activities:                    
Proceeds from issuance of Series B-1 convertible preferred stock, net of issuance costs                   2,994
Proceeds from exercise of stock options   227     455 384 657 777 915 442
Proceeds from issuance of common stock from the PIPE Investment               300,000 300,000  
Proceeds from the closing of the Merger               84,945 84,945  
Payment of offering costs from the closing of the Merger and PIPE Investment               (33,968) (34,132)  
Repayment of financing obligations         (359) 0 (359) (359) (359) (244)
Proceeds from long-term debt, net of issuance costs         31,882 0 31,882 31,882 31,882 22,438
Repayments of Long-term Debt                 (5,422) (8,404)
Net cash provided by financing activities   227     31,978 384 32,180 383,277 377,829 17,226
Effect of exchange rate changes on cash and cash equivalents           (10) 0      
Net increase (decrease) in cash, cash equivalents and restricted cash   (36,620)     17,418 (64,801) 5,934 329,718 303,463 (12,637)
Cash, cash equivalents and restricted cash                    
Cash, cash equivalents and restricted cash at beginning of period 271,547 308,167 10,638 22,122 4,704 308,167 4,704 4,704 4,704 17,341
Cash, cash equivalents and restricted cash at end of period 243,366 271,547 334,422 10,638 22,122 243,366 10,638 334,422 308,167 4,704
Supplemental disclosure of cash flow information                    
Transfer of inventory to property and equipment   0       0 46 0 0 86
Capital expenditures incurred but not yet paid   2,391     1,335 4,256 2,962 3,123 2,936 1,100
Capitalization of stock compensation           57 27      
Issuance of warrant to purchase common stock       0 1       0 112
Deferred offering costs included in accounts payable               1,770 1,943  
Conversion of convertible preferred stock to common stock               75,877 75,877  
Initial fair value of contingent earn-out liability recognized in connection with the closing of the Merger               67,021 67,021  
Initial fair value of contingently issuable common stock liability recognized in connection with the closing of the Merger               11,670 11,670  
Conversion of common stock warrants to common stock in connection with the closing of the Merger               880 880  
Initial fair value of public warrants in connection with the closing of the Merger               23,636 23,636  
Issuance of a nonrecourse promissory note with officer                   350
As Previously Reported                    
Cash flows from operating activities:                    
Net loss   (14,551)   (22,371) (13,755)   (36,126) (13,375) (10,858) (27,392)
Adjustments to reconcile net loss to net cash used in operating activities:                    
Depreciation and amortization   948     452   1,102 1,948 2,895 1,065
Write-off of inventory   324           400 2,132  
Adjustment to property and equipment for sales type leases   (321)             (91)  
Loss from impairment of property and equipment   96 1,656         1,656 1,869  
Adjustment to property and equipment for sales type leases               659 617  
Stock-based compensation   5,190     1,082   1,617 4,013 8,511 662
Noncash interest expense   5     2,344   5,455 5,561 5,245 25
Noncash lease expense   197                
Provision recorded for allowance for doubtful accounts         (63)   (63) (63) (13) 47
Loss on extinguishment of debt     865 11,820     11,820 12,685 12,685 66
Change in fair value of derivative liability     (475) 795 1,425   2,220 1,745 1,745  
Change in fair value of common stock warrant liability     (42) 185 736   921 879 879  
Change in fair value of contingent earn-out liability   (4,226) (31,818)         (31,818) (46,212)  
Change in fair value of contingently issuable common stock liability   (1,472) (5,718)         (5,718) (6,406)  
Change in fair value of public warrant liability   (5,586) (3,152)         (3,152) (12,606)  
Changes in operating assets and liabilities                    
Accounts receivable   (2,112)     (874)   (1,335) (5,866) (5,063) (464)
Inventory   (6,985)     (433)   (1,173) (10,836) (17,479) (1,471)
Commission assets   (351)     (391)   (742) (1,102) (3,072) (1,785)
Contract assets   108     (119)   (239) (2,582) (4,877)  
Other assets   0     0   0 0 0 0
Prepaid expenses and other current assets   (5,280)     (4,104)   (7,495) (12,772) (10,079) (375)
Accounts payable   (1,867)     1,194   5,361 2,264 (7) 1,915
Deferred revenue   2,778     (621)   253 2,459 4,968 2,341
Deferred rent   (468)     (11)   152 397 457 (34)
Warranty reserve             (42) (42) (42) (14)
Accrued expenses and other current liabilities         1,100   1,360 2,183 5,174 2,160
Accrued expenses and other current liabilities   (2,065)                
Operating lease liability   (229)               0
Net cash used in operating activities   (35,867)     (12,038)   (16,954) (50,477) (69,628) (23,254)
Cash flows from investing activities:                    
Development of internal-use software   (646)             (1,028)  
Purchases of property and equipment   (323)     (2,522)   (9,292) (3,082) (3,710) (6,609)
Net cash used in investing activities   (969)     (2,522)   (9,292) (3,082) (4,738) (6,609)
Cash flows from financing activities:                    
Proceeds from issuance of Series B-1 convertible preferred stock, net of issuance costs                   2,994
Proceeds from exercise of stock options   216     455   657 777 915 442
Proceeds from issuance of common stock from the PIPE Investment               300,000 300,000  
Proceeds from the closing of the Merger               84,945 84,945  
Payment of offering costs from the closing of the Merger and PIPE Investment               (33,968) (34,132)  
Repayment of financing obligations         (359)   (359) (359) (359) (244)
Proceeds from long-term debt, net of issuance costs         31,882   31,882 31,882 31,882 22,438
Repayments of Long-term Debt                 (5,422) (8,404)
Net cash provided by financing activities   216     31,978   32,180 383,277 377,829 17,226
Net increase (decrease) in cash, cash equivalents and restricted cash   (36,620)     17,418   5,934 329,718 303,463 (12,637)
Cash, cash equivalents and restricted cash                    
Cash, cash equivalents and restricted cash at beginning of period 271,547 308,167 10,638 22,122 4,704 308,167 4,704 4,704 4,704 17,341
Cash, cash equivalents and restricted cash at end of period   271,547 334,422 10,638 22,122   10,638 334,422 308,167 4,704
Supplemental disclosure of cash flow information                    
Transfer of inventory to property and equipment   4,620         46 9,648 12,949 86
Capital expenditures incurred but not yet paid   1,693     0   0 0 347 0
Capitalization of stock compensation             0      
Issuance of warrant to purchase common stock         1       1 112
Deferred offering costs included in accounts payable               1,760 1,932  
Conversion of convertible preferred stock to common stock               75,877 75,877  
Initial fair value of contingent earn-out liability recognized in connection with the closing of the Merger               66,845 67,021  
Initial fair value of contingently issuable common stock liability recognized in connection with the closing of the Merger               11,670 11,670  
Conversion of common stock warrants to common stock in connection with the closing of the Merger               880 880  
Initial fair value of public warrants in connection with the closing of the Merger               23,636 23,636  
Issuance of a nonrecourse promissory note with officer                   350
Adjustment                    
Cash flows from operating activities:                    
Net loss   750   (606) 249   (357) (2,301) (30) (1,035)
Adjustments to reconcile net loss to net cash used in operating activities:                    
Depreciation and amortization   138     0   0 0 0 0
Write-off of inventory   0           0 0  
Adjustment to property and equipment for sales type leases   (304)             0  
Loss from impairment of property and equipment   0 0         0 0  
Adjustment to property and equipment for sales type leases               0 0  
Stock-based compensation   (1,263)     (773)   (241) 2,019 1,085 917
Noncash interest expense   0     0   0 0 0 0
Noncash lease expense   0                
Provision recorded for allowance for doubtful accounts         0   0 0 0 0
Loss on extinguishment of debt     0 0     0 0 0 0
Change in fair value of derivative liability     0 0 0   0 0 0  
Change in fair value of common stock warrant liability     0 0 0   0 0 0  
Change in fair value of contingent earn-out liability   1,148 (791)         (791) (1,148)  
Change in fair value of contingently issuable common stock liability   0 0         0 0  
Change in fair value of public warrant liability   0 0         0 0  
Changes in operating assets and liabilities                    
Accounts receivable   0     0   0 0 0 0
Inventory   5,675     (47)   720 10,100 14,043 1,156
Commission assets   0     0   0 0 0 0
Contract assets   0     0   0 (895) 0  
Other assets   141     7   13 23 32 (173)
Prepaid expenses and other current assets   (291)     377   208 1,237 931 (641)
Accounts payable   1,012     (235)   (1,862) (2,024) 772 (1,100)
Deferred revenue   (201)     (185)   (100) (107) (136) 45
Deferred rent   468     0   0 0 0 0
Warranty reserve             0 0 0 0
Accrued expenses and other current liabilities         206   281 651 (2,702) 483
Accrued expenses and other current liabilities   (368)                
Operating lease liability   (468)               0
Net cash used in operating activities   6,437     (401)   (1,338) 7,912 12,847 (348)
Cash flows from investing activities:                    
Development of internal-use software   (82)             0  
Purchases of property and equipment   (6,366)     401   1,338 (7,912) (12,847) 348
Net cash used in investing activities   (6,448)     401   1,338 (7,912) (12,847) 348
Cash flows from financing activities:                    
Proceeds from issuance of Series B-1 convertible preferred stock, net of issuance costs                   0
Proceeds from exercise of stock options   11     0   0 0 0 0
Proceeds from issuance of common stock from the PIPE Investment               0 0  
Proceeds from the closing of the Merger               0 0  
Payment of offering costs from the closing of the Merger and PIPE Investment               0 0  
Repayment of financing obligations         0   0 0 0 0
Proceeds from long-term debt, net of issuance costs         0   0 0 0 0
Repayments of Long-term Debt                 0 0
Net cash provided by financing activities   11     0   0 0 0 0
Net increase (decrease) in cash, cash equivalents and restricted cash   0     0   0 0 0 0
Cash, cash equivalents and restricted cash                    
Cash, cash equivalents and restricted cash at beginning of period $ 0 0 0 0 0 $ 0 0 0 0 0
Cash, cash equivalents and restricted cash at end of period   0 $ 0 $ 0 0   0 0 0 0
Supplemental disclosure of cash flow information                    
Transfer of inventory to property and equipment   (4,620)         0 (9,648) (12,949) 0
Capital expenditures incurred but not yet paid   $ 698     1,335   2,962 3,123 2,589 1,100
Capitalization of stock compensation             $ 27      
Issuance of warrant to purchase common stock         $ 0       (1) 0
Deferred offering costs included in accounts payable               10 11  
Conversion of convertible preferred stock to common stock               0 0  
Initial fair value of contingent earn-out liability recognized in connection with the closing of the Merger               176 0  
Initial fair value of contingently issuable common stock liability recognized in connection with the closing of the Merger               0 0  
Conversion of common stock warrants to common stock in connection with the closing of the Merger               0 0  
Initial fair value of public warrants in connection with the closing of the Merger               $ 0 $ 0  
Issuance of a nonrecourse promissory note with officer                   $ 0